Maintaining a strong equity base and high liquidity
First written in FY2018. 21 of 22 entries say "Restated". Latest entry: FY2024-Q3.
7 other companies' latest entry also says "Restated".
- FY2024-Q3RestatedAnnual report
「The equity ratio was 83.2% (81.9% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place, and the equity ratio rose from 81.9% at the end of the previous fiscal year to 83.2%. - FY2024-Q2RestatedAnnual report
「The equity ratio was 82.0% (81.9% at the end of the previous consolidated fiscal year).」
Under its policy of prioritizing a strong equity base and high liquidity, the company reported an equity ratio of 82.0%. - FY2024-Q1RestatedAnnual report
「The equity ratio was 82.1% (81.9% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place, and the equity ratio rose from 81.9% at the end of the previous fiscal year to 82.1%. - FY2023-Q3RestatedAnnual report
「The equity ratio was 83.5% (83.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place, and the equity ratio rose from 83.4% at the end of the previous fiscal year to 83.5%. - FY2023-Q2RestatedAnnual report
「The equity ratio was 83.6% (83.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place, and the equity ratio rose from 83.4% at the end of the previous fiscal year to 83.6%. - FY2023-Q1RestatedAnnual report
「The equity ratio was 83.1% (83.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place. The equity ratio declined from 83.4% at the end of the previous fiscal year to 83.1%. - FY2022RestatedAnnual report
「The equity ratio was 83.4%.」
The company continued its policy of prioritizing a strong equity base and high liquidity, and the equity ratio was unchanged at 83.4% from the end of the previous fiscal year. - FY2022-Q3RestatedAnnual report
「The equity ratio was 83.0% (83.4% at the end of the previous consolidated fiscal year).」
The company continues to prioritize a strong equity base and high liquidity. The equity ratio declined from 83.4% at the end of the previous fiscal year to 83.0%. - FY2022-Q2RestatedAnnual report
「The equity ratio was 83.5% (83.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place, and the equity ratio rose from 83.4% at the end of the previous fiscal year to 83.5%. - FY2022-Q1RestatedAnnual report
「The equity ratio was 83.1% (83.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place. The equity ratio declined from 83.4% at the end of the previous fiscal year to 83.1%. - FY2021RestatedAnnual report
「The equity ratio was 83.4%.」
The company continued its policy of prioritizing a strong equity base and high liquidity. The equity ratio rose from 81.4% at the end of the previous fiscal year to 83.4%, and cash and cash equivalents amounted to ¥77,305 million. - FY2021-Q3RestatedAnnual report
「The equity ratio was 82.2% (81.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base remains in place, and the equity ratio rose from the end of the previous fiscal year to 82.2%. - FY2021-Q2RestatedAnnual report
「The equity ratio was 81.7% (81.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place, and the equity ratio rose from 81.4% at the end of the previous fiscal year to 81.7%. Cash and cash equivalents amounted to ¥74,666 million. - FY2021-Q1RestatedAnnual report
「The equity ratio was 82.0% (81.4% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base and high liquidity remains in place, and the equity ratio rose from 81.4% at the end of the previous fiscal year to 82.0%. - FY2020-Q3RestatedAnnual report
「The equity ratio was 78.9% (77.7% at the end of the previous consolidated fiscal year).」
The policy of prioritizing a strong equity base remains in place, and the equity ratio rose from 77.7% at the end of the previous fiscal year to 78.9%. - FY2020-Q2RestatedAnnual report
「The equity ratio was 79.7% (77.7% at the end of the previous consolidated fiscal year).」
Under its policy of prioritizing a strong equity base, the equity ratio rose from 77.7% at the end of the previous fiscal year to 79.7%. Cash and cash equivalents amounted to ¥65,469 million, and the policy of maintaining high liquidity also remains in place. - FY2020-Q1RestatedAnnual report
「The equity ratio was 77.6% (77.7% at the end of the previous consolidated fiscal year).」
The equity ratio declined from 77.7% at the end of the previous fiscal year to 77.6%. The policy of prioritizing a strong equity base and high liquidity remains in place. - FY2019RestatedAnnual report
「The equity ratio at the end of the consolidated fiscal year was 77.7%, essentially unchanged from the previous year and considered to be at a sound level.」
The company continued its policy of prioritizing a strong equity base and high liquidity, reporting an equity ratio of 77.7% and cash and cash equivalents of ¥58,555 million. - FY2019-Q3RestatedAnnual report
「The equity ratio was 78.1% (74.7% at the end of the previous consolidated fiscal year).」
The equity ratio rose from 74.7% at the end of the previous consolidated fiscal year to 78.1%, indicating a level consistent with the policy of prioritizing a strong equity base. - FY2019-Q2RestatedAnnual report
「The equity ratio was 76.9% (74.7% at the end of the previous consolidated fiscal year).」
The equity ratio rose from 74.7% at the end of the previous consolidated fiscal year to 76.9%, indicating a level consistent with the policy of prioritizing a strong equity base. - FY2019-Q1RestatedAnnual report
「The equity ratio was 75.6% (74.7% at the end of the previous consolidated fiscal year).」
The equity ratio rose from 74.7% at the end of the previous consolidated fiscal year to 75.6%, indicating a level consistent with the policy of prioritizing a strong equity base. - FY2018First statedAnnual report
「Given the high business risks in the industry, the company places importance on maintaining a strong equity base. The equity ratio at the end of the consolidated fiscal year was 74.7%, essentially unchanged from the previous year and considered to be at a sound level. The company strives to maintain high liquidity so that it can respond flexibly to important research and development investments.」
In light of the business risks in the pharmaceutical industry, the company has disclosed separately for the first time a policy of maintaining an equity ratio of 74.7% and high liquidity.